High Exposure of Intravenous Alemtuzumab Is Associated with Increased Risk of Double-Stranded DNA Viral Infections in Patients with Non-Malignant Disease Undergoing Allogeneic HCT.

Gabriel Salinas Cisneros, Janel Renee Long-Boyle, William C. Temple, Julia Chu, Serine Avagyan, Lena E. Winestone, Christine S. Higham, Kristin A. Shimano, James N. Huang, Michelle Hermiston, Sandhya Kharbanda, Christopher C. Dvorak